HCmed Innovations (HCmed) confirmed on December 27, 2017, that Vivo capital, through the fund under its management, PANDA Fund, L.P., has become its strategic investor.
Nebulization is a time-tested approach for delivering aerosol to targeted pulmonary areas, especially for inhalation therapies that require deep lung deposition.
The principle of nebulizer therapy can be tracked as far back as 4000 years ago. Since the earliest days of recorded human history, people have been suffering from throat and chest pains.